NYSE:CHE - Chemed Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $306.42 +5.00 (+1.66 %) (As of 12/13/2018 01:42 AM ET)Previous Close$301.42Today's Range$301.34 - $310.9952-Week Range$234.15 - $335.99Volume77,388 shsAverage Volume135,459 shsMarket Capitalization$4.85 billionP/E Ratio57.17Dividend Yield0.40%Beta1.19 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Chemed Corporation provides hospice and palliative care services in the United States. It operates through two segments, VITAS and Roto-Rooter. The VITAS segment offers direct medical services, as well as spiritual and emotional counseling services to terminally ill patients. This segment offers its services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and operated territories, independent contractor-operated territories, and franchised locations. This segment also manufactures and sells products and equipment, including drain cleaning machines and drain cleaning solutions. The company was founded in 1970 and is headquartered in Cincinnati, Ohio. Receive CHE News and Ratings via Email Sign-up to receive the latest news and ratings for CHE and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Home health care services Sub-IndustryHealth Care Services SectorMedical Current SymbolNYSE:CHE Previous Symbol CUSIP16359R10 Webwww.chemed.com Phone513-762-6690 Debt Debt-to-Equity Ratio0.23 Current Ratio1.14 Quick Ratio1.11 Price-To-Earnings Trailing P/E Ratio57.17 Forward P/E Ratio26.86 P/E Growth2.66 Sales & Book Value Annual Sales$1.67 billion Price / Sales2.94 Cash Flow$8.0616 per share Price / Cash Flow38.01 Book Value$33.84 per share Price / Book9.05 Profitability EPS (Most Recent Fiscal Year)$5.36 Net Income$98.17 million Net Margins11.73% Return on Equity35.13% Return on Assets20.40% Miscellaneous Employees14,813 Outstanding Shares16,010,000Market Cap$4.85 billion OptionableOptionable Chemed (NYSE:CHE) Frequently Asked Questions What is Chemed's stock symbol? Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE." How often does Chemed pay dividends? What is the dividend yield for Chemed? Chemed declared a quarterly dividend on Friday, November 2nd. Investors of record on Monday, November 12th will be paid a dividend of $0.30 per share on Monday, December 3rd. This represents a $1.20 dividend on an annualized basis and a dividend yield of 0.39%. The ex-dividend date is Thursday, November 8th. View Chemed's Dividend History. How will Chemed's stock buyback program work? Chemed declared that its Board of Directors has approved a share buyback plan on Wednesday, March 7th 2018, which permits the company to buyback $150,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Shares buyback plans are generally an indication that the company's board believes its stock is undervalued. How were Chemed's earnings last quarter? Chemed Co. (NYSE:CHE) released its quarterly earnings data on Monday, October, 29th. The company reported $3.07 earnings per share for the quarter, topping the Zacks' consensus estimate of $2.80 by $0.27. The company had revenue of $444.15 million for the quarter, compared to analyst estimates of $445.16 million. Chemed had a net margin of 11.73% and a return on equity of 35.13%. The firm's revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.15 earnings per share. View Chemed's Earnings History. When is Chemed's next earnings date? Chemed is scheduled to release their next quarterly earnings announcement on Wednesday, February 13th 2019. View Earnings Estimates for Chemed. What guidance has Chemed issued on next quarter's earnings? Chemed updated its FY18 earnings guidance on Monday, October, 29th. The company provided EPS guidance of $11.80-11.90 for the period, compared to the Thomson Reuters consensus estimate of $11.47. Chemed also updated its FY 2018 guidance to $11.80-11.90 EPS. What price target have analysts set for CHE? 3 brokers have issued 12 month target prices for Chemed's stock. Their predictions range from $275.00 to $390.00. On average, they anticipate Chemed's share price to reach $328.6667 in the next twelve months. This suggests a possible upside of 7.3% from the stock's current price. View Analyst Price Targets for Chemed. What is the consensus analysts' recommendation for Chemed? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed. Has Chemed been receiving favorable news coverage? News stories about CHE stock have been trending very positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Chemed earned a news impact score of 3.6 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near term. Who are some of Chemed's key competitors? Some companies that are related to Chemed include Amedisys (AMED), LHC Group (LHCG), Addus Homecare (ADUS), BioScrip (BIOS), Civitas Solutions (CIVI) and New York Health Care (BBAL). Who are Chemed's key executives? Chemed's management team includes the folowing people: Mr. Kevin J. McNamara, CEO, Pres & Director (Age 64)Mr. David P. Williams, Exec. VP & CFO (Age 57)Ms. Naomi C. Dallob, VP, Chief Legal Officer & Sec. (Age 64)Mr. Spencer S. Lee, Exec. VP (Age 62)Mr. Nicholas Michael Westfall, Exec. VP (Age 39) Who are Chemed's major shareholders? Chemed's stock is owned by a number of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (11.63%), BlackRock Inc. (10.48%), Neuberger Berman Group LLC (4.32%), Acadian Asset Management LLC (3.58%), Riverbridge Partners LLC (3.04%) and Fisher Asset Management LLC (2.95%). Company insiders that own Chemed stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed. Which institutional investors are selling Chemed stock? CHE stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, JPMorgan Chase & Co., JPMorgan Chase & Co., Gamco Investors INC. ET AL, Paloma Partners Management Co, Hsbc Holdings PLC, Deutsche Bank AG and Gabelli Funds LLC. Company insiders that have sold Chemed company stock in the last year include David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed. Which institutional investors are buying Chemed stock? CHE stock was bought by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, First Trust Advisors LP, Allianz Asset Management GmbH, Canada Pension Plan Investment Board, Rehmann Capital Advisory Group, Schroder Investment Management Group, Capital Fund Management S.A. and Janus Henderson Group PLC. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed. How do I buy shares of Chemed? Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Chemed's stock price today? One share of CHE stock can currently be purchased for approximately $306.42. How big of a company is Chemed? Chemed has a market capitalization of $4.85 billion and generates $1.67 billion in revenue each year. The company earns $98.17 million in net income (profit) each year or $5.36 on an earnings per share basis. Chemed employs 14,813 workers across the globe. What is Chemed's official website? The official website for Chemed is http://www.chemed.com. How can I contact Chemed? Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690. MarketBeat Community Rating for Chemed (NYSE CHE)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 207 (Vote Outperform)Underperform Votes: 292 (Vote Underperform)Total Votes: 499MarketBeat's community ratings are surveys of what our community members think about Chemed and other stocks. Vote "Outperform" if you believe CHE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHE will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 12/13/2018 by MarketBeat.com StaffFeatured Article: How accurate is the Rule of 72?